Behavioral tests, including the Y-maze working memory task and the Box Maze spatial learning task, helped provide evidence that intranasal GHK-Cu treatment can enhance cognitive performance in a mouse model of AD
Should these symptoms prevail, there could be an additional need to support the bodys natural antioxidant potential by using high-quality glutathione-based suppositories, in order to promote natural antioxidant activities and minimise free radical damage
The approved dosing for both indications involves subcutaneous injection once weekly, with gradual dose escalation from 2.5 mg to maintenance doses of 5 mg, 10 mg, or 15 mg based on individual response and tolerability
Injectable GHK-Cu provides systemic copper peptide benefits like collagen synthesis, antioxidant effects, and reduced inflammation
Are We Any Closer to Registering a New Treatment
We observed that TS induced elevated gluten exorphin C